Q3 Loss Widens to $66.2M as Kodiak Raises $69M Through ATM Sales
KOD has more than doubled off its 52-week low of $18.05 on light trading volume (0.3× avg).
Summary
Kodiak posted a Q3 2026 net loss of $66.2M, or $1.05 per share, versus $61.5M ($1.16 per share) a year ago — the dollar loss widened but the per-share loss narrowed on a larger share count. After quarter-end the company raised $69M net through its at-the-market program, the $350M shelf filed October 20th, and expects its $88.7M quarter-end cash balance plus those proceeds to fund operations into 2027. That extends the runway past the going-concern warning in the Q2 10-Q, which flagged cash possibly not covering the next 12 months. The clinical story is the bigger driver: Zenkuda met the DAYBREAK Phase 3 primary endpoint and management still targets a multi-indication BLA submission by year-end. Next hard data point is KSI-101 PEAK topline results expected December 2026.
At the time of this announcement, KOD was trading at $108.25 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $18.05 to $112.31. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.